| Product Name | MF | CAS | Details |
|---|
| bortezoMib iMpurity A | Details |
| (S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | C14H14N4O2 | 289472-80-6 | Details |
| bortezoMib iMpurity C | Details |
| (S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID | C14H13N3O3 | 114457-94-2 | Details |
| ((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid | C19H25BN4O4 | 1132709-14-8 | Details |
| 2-Pyrazinecarboxamide, N-[(1S)-2-[(3-hydroxy-3-methyl-1-oxobutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]- | C19H22N4O4 | 2379402-85-2 | Details |
| ((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid | C19H25BN4O4 | 1132709-15-9 | Details |
| N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | C19H24N4O3 | 289472-81-7 | Details |
| 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- | C19H24N4O4 | 886979-78-8 | Details |
| 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- | C19H24N4O4 | 886979-81-3 | Details |
| (S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | C19H22N4O3 | 862894-96-0 | Details |
| Bortezomib Impurity P | Details |
| NA | Details |
| Bortezomib impurity 1 | Details |
| Bortezomib Impurity 2 | Details |
| (S,E)-N-(1-((3-methylbut-1-en-1-yl)amino)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide | C19H22N4O2 | 862895-00-9 | Details |
| 2-Pyrazinecarboxamide, N-[(1S)-2-[[(1Z)-3-methyl-1-buten-1-yl]amino]-2-oxo-1-(phenylmethyl)ethyl]- | C19H22N4O2 | 2276538-67-9 | Details |
| bortezoMib iMpurity H | C19H24N4O2 | 1446194-56-4 | Details |
| N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester | C15H15N3O3 | 73058-37-4 | Details |
| Bortezomib Impurity 7 | Details |
| ((R)-1-((S)-2-AMino-3-phenylpropanaMido)-3-Methylbutyl)boronic acid | C14H23BN2O3 | 948294-96-0 | Details |
| Bortezomib Impurity 9 | C28H34BN5O5 | 1194235-41-0 | Details |
| 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- | C57H69B3N12O9 | 390800-88-1 | Details |
| Bortezomib Impurity 12 Hydrochloride | Details |
| Olanzapine | C17H20N4S | 132539-06-1 | Details |
| Olanzapine ThiolactaM IMpurity | C17H20N4OS | 1017241-36-9 | Details |
| Olanzapine LactaM IMpurity | C17H20N4O2 | 1017241-34-7 | Details |
| Olanzapine ThioacetoxyMethylidene IMpurity Discontinued | C17H20N4O2S | 1320360-87-9 | Details |
| HydroxyMethylidene thione | C15H18N4OS | 1320360-86-8 | Details |
| 13-Cis Vitamin A Palmitate | C36H60O2 | 26771-20-0 | Details |
| 9-cis-Retinyl Palmitate | C36H60O2 | 34356-29-1 | Details |
| 9-CIS-RETINOL ACETATE | C22H32O2 | 29584-22-3 | Details |
| 9-cis,13-cis-Retinyl palmitate | C36H60O2 | 34356-30-4 | Details |
| Topiramate | C12H21NO8S | 97240-79-4 | Details |
| Topiramate Impurity 6 | C17H30N2O9S | 876403-98-4 | Details |
| 4,5-Desisopropylidene Topiramate | C9H17NO8S | 106881-41-8 | Details |
| Topiramate Impurity 6 | C25H39NO15S | 950603-46-0 | Details |
| TopiraMate N-Methyl IMpurity | C13H23NO8S | 97240-80-7 | Details |
| Naltrexone methylbromide | C21H26BrNO4 | 73232-52-7 | Details |
| Methyhaaltrexone Bromideimpurity 2 | 1005410-39-8 | Details |
| β-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-(N-ethylsulfamate) | C14H25NO8S | 205248-77-7 | Details |
| 13-cis-Retinyl Acetate | C22H32O2 | 34356-31-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 | ||||